Biography
Dr Amy Teh has a strong commitment to her patients, taking a compassionate approach to care for their physical and emotional needs throughout treatment. She is an experienced radiation oncologist who supports her patients every step of the way.
Dr Amy Teh is a senior Radiation Oncologist at Icon Cancer Centre Wahroonga and Gosford, specialising in the treatment of prostate and breast cancer. She graduated with Honours from the University of New South Wales in 2001 and completed her Radiation Oncology training at Peter MacCallum Cancer Centre in Melbourne. Dr Teh subsequently undertook a Clinical Research Fellowship at Princess Margaret Hospital in Toronto, Canada, where she was the recipient of the Phyllis Hantho Breast Cancer Research Fund and was awarded the Weekend to End Breast Cancer Research Fellowship for her research.
Dr Teh returned to Australia in 2009 and has developed extensive expertise in advanced radiotherapy, particularly in prostate cancer. She holds certification from the Seattle Prostate Institute in both low-dose-rate (LDR) and high-dose-rate (HDR) prostate brachytherapy, as well as in Image-Guided Stereotactic Radiotherapy through ESTRO in Lille, France.
Dr Teh has a particular clinical and research interest in adaptive radiotherapy and the integration of artificial intelligence into radiation oncology. She has been at the forefront of the implementation of AI-enabled adaptive radiotherapy for prostate cancer in Australia. She was an invited member of the New Techniques and Technology Committee of TROG (Trans-Tasman Radiation Oncology Group), Australia's leading radiation oncology research group, and serves on the RANZCR (Royal Australian and New Zealand College of Radiologists) AI Committee and the Radiation Oncology Alliance Adaptive Radiotherapy Working Group, developing clinical guidelines for the safe implementation of AI and online adaptive radiotherapy in Australia and New Zealand.
Dr Teh is actively involved in clinical research and prostate cancer trials through TROG and ANZUP. Her research spans both breast and prostate cancer and includes advanced radiotherapy techniques, prostate brachytherapy, PSMA imaging and AI-enabled adaptive radiotherapy. She has led and contributed to national and international clinical trials, published extensively in the field, and remains committed to translating the latest advances in cancer treatment into improved outcomes for patients.
Dr Teh has a strong commitment to medical education and academic research. She has twice received the University of Sydney's Excellence in Teaching Award and is currently a Clinical Senior Lecturer at the Australian National University. She has served as an Examiner for the RANZCR specialist training program in Radiation Oncology and continues to contribute to medical education.
In addition to her clinical and academic work, Dr Teh has contributed to global health through participation in a volunteer oncology outreach team to the Solomon Islands.
Dr Teh's work focuses on translating advances in radiation oncology—including precision imaging, artificial intelligence and adaptive radiotherapy—into improved treatment and care for patients with cancer.
Publications
Byrne M, Teh AYM, Archibald-Heeren B, Hu Y, Rijken J, Luo S, Aland T, Greeg P. Intrafraction motion and margin assessment for Ethos online adaptive radiotherapy treatments of the prostate and seminal vesicles. Advances in Radiation Oncology. 2024;9(3):101405. doi:10.1016/j.adro.2023.101405.
Shepherd M, Thompson K, Aland T, Booth J, de Leon J, Hargrave C, Jameson MG, Ng SP, Teh AYM, Anderson N. Adapting to the Future: Introducing the Radiation Oncology Alliance Adaptive Radiotherapy Working Group. Journal of Medical Imaging and Radiation Oncology. 2025;69(7):763–767. doi:10.1111/1754-9485.70023.
Teh AY, Walsh L, Purdie TG, Mosseri A, Xu W, Levin W, Koch CA, Fyles A, Liu FF, Cho BC. Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy—a feasibility and toxicity study. Radiotherapy and Oncology. 2012;102(1):89–95. doi:10.1016/j.radonc.2011.10.015.
Roos D, Teh AYM, Fitzpatrick K, Gunn M; RANZCR Artificial Intelligence Committee. The RANZCR Artificial Intelligence Committee: Position statement on autonomous AI. Journal of Medical Imaging and Radiation Oncology. 2024;68(7):851–852. doi:10.1111/1754-9485.13756.
Kwan TN, Spremo S, Teh AYM, McHarg D, Thangasamy I, Woo HH. Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer. Prostate International. 2021;9(2):107–112. doi:10.1016/j.prnil.2020.07.008.